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Abstract: The COVID-19 pandemic represents a major stressor for the psychological health of people
worldwide. In the UK, the COVID19-Psychological Research Consortium Study (C19PRC) launched
to evaluate the psychological impact of COVID-19 in the general population and its implications.
The project was then extended to Italy and several other countries. This article provides an overview
of the Italian C19PRC study and its replication of two specific findings from the UK C19PRC.
In the first part, the relationship between anxiety and somatic symptomatology is examined. In the
second part, we analyze the association between several factors and psychological health outcomes:
depression/anxiety, traumatic stress, COVID-19 anxiety. In line with the study conducted in the UK,
an online survey was administered to the adult Italian general population. The sample included 1038
respondents (age, mean = 49.94, SD = 16.14, 51.15% females) taken from four regions: Lombardia,
Veneto, Lazio, and Campania. The relationship between predictors and outcomes was evaluated
by means of logistic regression models. Somatic indices showed a positive association with anxiety,
worse somatic symptoms were associated with mourning a loss of a beloved one due to COVID-
19 and with precarious health conditions. Females showed a higher incidence of psychological
issues. No differences in anxiety, depression, and traumatic stress were found across regions but
the Campania region showed the most severe somatic symptomatology. In the second analysis,
the factors associated with more severe psychological outcomes (i.e., anxiety and/or depression,
traumatic stress, and COVID-19 related anxiety) were younger age, the presence of minors in the
household, traumatic stressors, and precarious health conditions. No differences across regions
emerged. The Italian results correspond to the UK findings for anxiety, depression, and traumatic
stress. Both in the UK and Italy, the factors associated with worse psychological health were gender
(female), younger age, having children, pre-existing health issues (both for oneself or someone close),
and the moderate/high perceived risk of contracting COVID-19 within one month. In Italy, unlike the
UK, lower household income and having (had) COVID-19 were not associated with poorer mental
health. The psychological impact of COVID-19 can last for months; future research should explore all
aspects of the psychological burden of COVID-19 in order to implement psychological interventions
and promote psychological health.
Keywords: COVID-19; psychological health; general population; somatic symptoms; anxiety; depression
1. Introduction
Coronavirus-19 (COVID-19) is a virus first identified in 2019 that has led to an ongoing
health emergency worldwide, with high infection rates and mortality [1]. The World
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Health Organization recognized the outbreak as a Public Health Emergency of International
Concern in January 2020, and as a pandemic in March 2020. Infection can cause systemic
organ disease and some categories of people are more at risk in developing severe health
consequences, such as those over 70 years old, pregnant women, and those who have
pre-existing health conditions (e.g., cardiovascular disease) [2]. However, everyone can be
infected and the long-term health consequences—also in its milder presentations—are still
not fully understood.
Given the high transmissibility of COVID-19, to contain contagion many countries
have adopted restrictive measures such as lockdown, quarantine, social distancing, and lim-
its to movements and travel. These measures have serious economic as well as social
implications. Therefore, these aspects of the pandemic extend beyond the health domain.
The lives of millions of people have been affected, potentially increasing anxiety, loneliness,
and distress. Some of these behavioral responses have been noted and commented in the
media. Moreover, the measures have produced various responses, ranging from resistance,
stockpiling of food supplies, denial, and beliefs in conspiracy theories. Some behavioral
changes have the potential to affect the course of the pandemic itself [3].
The impact of the pandemic can be analyzed from social, psychological, and economic
perspectives. Some authors have claimed that we are in the presence of a mental health
emergency [4]. Over time fear, anxiety, worry, and depression have grown among peo-
ple [5]. According to some, the psychological impact of COVID-19 may be greater than the
threat represented by the physical disease itself, especially for vulnerable individuals [6].
A growing number of studies have highlighted psychological symptoms and issues in the
clinical and general population [7–9].
A focus on the clinical population and on specific risk categories (e.g., young adults,
pregnant women, health professionals, caregivers, the elderly) is useful to highlight the
needs of these groups [10–12]. However, at the same time, it is important to direct attention
to the general population to identify psychological and behavioral patterns.
Several studies have been conducted during the acute phase when contagions reached
their peak. The effect of stressors and the psychological symptoms may persist or evolve
over periods or months [13]. This is the case when people experience fear (for self and for
significant others), stigmatization, and severe psychological symptoms [14].
Italy was one of the first countries to face the COVID-19 emergency and in an especially
intense manner. In China, the city of Wuhan was put under quarantine on the 9th of January
2020. Already on/by the 21st of February 16 cases were confirmed in Lombardia and two
in Veneto (two Italian regions in the North). Cases grew quickly leading to shortfalls of
hospital beds, especially in intensive care units (ICU). The impact on the individual, social,
and economic life in Italy was significant. In Italy, as in other countries, the pandemic
did not affect all regions equally. Thus, national statistics can be misleading. An analysis
by region is important for at least two reasons: first, the north of Italy is divided in eight
regions but there are large differences in the impact even between these. Second, in Italy
the national health service has a regional structure, and different measures were taken
by different regions, (e.g., different testing effort, quarantine policy, individual mobilities,
the progression of social distancing, and local capacity of medical infrastructure) [15].
Third, the timeline of the virus varied by region. Lombardia was the first region to be
affected and remained also the region with most cases over time. This is a wealthy region
with high population density and its capital Milan is the second largest city in Italy.
In March 2020, a longitudinal, multi-country project was launched by the COVID-
19 Psychological Research Consortium (C19PRC) in the UK and then enlarged to other
countries [16]. The present study represents the opening article of the Italian C19PRC
project. Data was collected in Italy from 13 to 28 July 2020, after the contagion peak (end
of March) and after the end of the strict national lockdown (18 May). Many commercial
and social activities had restarted, and people were allowed to move beyond their own
towns. In mid-July, the number of contagions had a stable and decreasing trend, but there
were still preventive measures in place (e.g., social distancing, hygiene practices, masks).
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There was an awareness in the population that a second wave of contagions was possible
in all regions.
This study focused on four Italian regions selected because of their geographical
location, from the north (Lombardia, Veneto), center (Lazio), and south (Campania), and be-
cause of their infection rate when the survey was launched–at the beginning of July 2020–
from higher (Lombardia = 95,118 cases, Veneto = 19,432) to medium-lower (Lazio = 8389,
Campania = 4788) [17]. Indeed, when data was collected, from 13 to 18 July, in Italy a total
of 243,230 cases of COVID-19 had been registered, with 35,042 deaths. The regions that
registered the highest number of contagions were Lombardia and Veneto, while in the
center and south the outbreak was more contained.
According to the Italian Ministry of Health, the health services and policies are the
same in the Italian regions, but some independent regional choices are allowed. In the
North, Lombardia ran fewer tests than Veneto and Emilia Romagna. These regions adopted
proactive testing modalities and treatment strategies, testing a large number of people and
treating positive patients with mild symptoms at home. Therefore, we chose to compare
Lombardia and Veneto. Veneto is geographically next to Lombardia, they both have a
mix of large cities and small towns and, with respect to population, Lombardia is the
largest (10 million) and Veneto is the 5th largest region in Italy (nearly 5 million). The
other two regions also include some large cities (Rome in Lazio and Naples in Campania)
and are relatively large (5.8 million each). From 17 May 2020 the government passed
responsibility to single regions under the overall supervision of the Ministry of Health [18];
different measures in different regions were motivated by the underlying infections and
death trends.
Data from a substantial sample of the general population are useful to plan effec-
tive interventions. A range of variables have to be assessed due to the complexity of
the psychological, social, and cultural context of the pandemic. Some of them are: de-
mographics; socioeconomic status; political opinions; belongingness in the community;
public health knowledge; news broadcasting; risk perceptions; hygienic and preventive
practices; decision making (e.g., whether to vaccinate or not). Among the psychological
ones, post-traumatic stress, loneliness, anxiety, and depression should be assessed as well
as self-esteem, personality, and resilience.
Aims
This Italian C19PRC study uses data collected on a range of demographic, social,
and psychological variables from a sample of the general population in Italy. The aim
is to describe the effects of the pandemic in adults. Here we provide an overview of the
project, and an initial analysis, while additional detailed analyses will require further work.
In particular in this paper we focus on anxiety, depression, and stress related to COVID-19
and on the comparison with the same measurements from the first wave of the UK C19PRC
study [19,20]. Moreover, comparisons across four Italian regions—selected according to
geographic location and infection rate—are provided.
2. Methodological Section
2.1. Study Plan
The original complete survey from the UK is described by McBride and colleagues [16].
Our goal was to maintain the Consortium aims and measures, applying them to the Italian
population. Part of this data will be used to conduct further in-depth studies focusing
on specific topics described in detail in following papers. In line with the UK survey,
the Italian C19PRC study relied on an online survey provided by Qualtrics. R software was
used for all analyses [21]. The survey was administered in four Italian regions—Campania,
Lazio, Lombardia and Veneto. Ethical approval for this study was provided by the Ethical
Committee for Psychological Research of the University of Padua (protocol: 3818).
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2.2. Participants
The inclusion criteria were living in Italy and at least 18 years old. Participants were
excluded if survey completion time was below 11 minutes and 11 seconds or above three
days. All participants were informed about the study’s aims, their rights, and privacy
policies. All of them provided informed consent before completing the survey of the study,
conducted according to Ethical Principles and Code of Conduct of the Italian Association
of Psychology.
Adult participants (n = 1038) were recruited by the survey company Qualtrics from
an online research panel using stratified quota sampling to guarantee that the sample
characteristics of gender, age, household income, and region (Campania, Lazio, Lombardia,
and Veneto) matched the Italian population. After the completion of the survey online
(median time of completion = 41 min), each participant was reimbursed by Qualtrics.
The mean age of the total sample was 49.94 years (median = 51, SD = 16.14, range = 18–87),
and 51.15% were female (n = 531). Participants were recruited from the four selected re-
gions based on their population size: Campania (n = 227), Lazio (n = 234), Lombardia
(n = 391), Veneto (n = 186). Most of the participants were Italian (96.61%, n = 1003) and
with Caucasian ethnicity (74.66%, n = 775). A minority had only elementary or some sec-
ondary education (8.28%, n = 86), nearly half had completed high school (48.74%, n = 506)
with a further 42.97% having attained a higher level of education. Less than half were in
full employment (44.41%, n = 461), with 24.18% retired (n = 251). Married participants
comprised 57.99% (n = 602) whereas never married participants comprised 26.59% of the
sample (n = 276).
Only 14 participants tested positive for COVID-19 (1.35%). Two and a half percent
of the sample confirmed the presence of coronavirus cases among individuals living
in the same house, and 17.82% among friends or relatives. Finally, 10.50% of the par-
ticipants mourning a loss due to confirmed cases of COVID-19. Further information
about demographics is available in the Supplementary Materials (S1, Tables S1–S20 and
https://osf.io/nx2zd/).
2.3. Measures
In line with the aim of the original C19PRC-UK study, the measures remained the
same in order to allow cross-cultural comparison. Below, the measures that are relevant
for the present analysis are described. Items were translated into Italian. The full list is
available as Supplementary Material (Supplementary File S1 and https://osf.io/nx2zd/).
Sociodemographic variables: we collected the same information as the original C19PRC-
UK study [16]: location, presence of adults or minors in the house, income, and previous
health issues. We integrated these with further information (region, mourning for COVID-
19 human losses, perceived risk to contract COVID-19).
The Patient Health Questionnaire-15 (PHQ-15) [22] is a 15-item self-report measure based
on a 3-point Likert scale. It asks about the presence of somatic symptoms in the last 14 days.
In this study, we use both the total scores and the four subscales pain symptoms (0–6),
gastrointestinal symptoms (0–8), cardiopulmonary symptoms (0–8), and fatigue symptoms
(0–4). As in previous works [16–23] and for the same reasons, item 4 and item 13 were
excluded, lowering the maximum score to 26.
The Patient Health Questionnaire-9 (PHQ-9) [24] was used to measure nine symptoms of
depression, asking participants how often they have been bothered by each symptom over
the last 14 rated on a four-point Likert scale. The maximum score is 27, which is indicative
of a high level of depression. A cut-off score of 10 was used, corresponding to moderate
levels of depression [25].
The Generalized Anxiety Disorder 7-item Scale (GAD-7) [26] is a seven-item self-report
measure based on a four-point Likert scale. It asks participants about anxiety symptoms in
the last 14 days. The maximum score is 21, which is indicative of high levels of generalized
anxiety. A cut-off of 10 was used, corresponding to a moderately severe level of anxiety [27].
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The International Trauma Questionnaire (ITQ) [28] is a nine-item self-report measure
based on a 5-point Likert scale. Consistently with ICD-11 [29], it asks participants about
particular events or behaviors in the last 30 days, across the three symptom clusters of
re-experiencing, avoidance, and sense of threat (two items each). Another three items
measure functional impairment caused by these symptoms. The maximum score is 24,
and a score of ≥2 (Moderately) is considered endorsement of that symptom. A PTSD
diagnosis requires the endorsement of the three clusters and at least one indicator of
functional impairment [30,31].
COVID-19-related anxiety was measured through a single item, ‘How anxious are you
about the coronavirus COVID-19 pandemic?’, rated on a continuous scale from 0 to 100.
Higher values correspond to higher COVID-19 related anxiety.
2.4. Analytic Methods
In Section 3.1, scores of the COVID-19 anxiety variable were categorized into quintiles,
and the quintiles were dummy-coded with the lowest one used as the reference cate-
gory [20] Regression models were used to estimate the relationship between the COVID-19
anxiety quintiles and the PHQ-15 subscales (pain, gastrointestinal, cardiopulmonary, and fa-
tigue). Model 1 included the four dummy-coded COVID-19 anxiety variables as predictors
of the four PHQ-15 subscales. The regression coefficient for each dummy-coded variable
is interpreted as the mean difference between each quintile and the lowest one. Model 1
was also run separately with the total PHQ-15 summed scale score replacing the subscales.
In Model 2 the covariates (age, gender, income, pre-existing health problems, and GAD)
were included as predictors, with the addition of Italian region mourning for COVID-19
losses factors.
In Section 3.2, measures of depression (PHQ-9), generalized anxiety (GAD-7), trauma
symptoms relating to the pandemic (ITQ) and COVID-19 anxiety were considered as
dependent variables for three binary logistic regression models [19]. The predictor variables
were age, gender, living location, living alone, presence of children in the household,
income, pre-existing health conditions in self and someone close, and perceived risk of
infection over the next month. Italian region and mourning for COVID-19 losses factors
were included.
3. Results
3.1. Somatic Symptoms
Correlations for all the variables included in Models 1 and 2 are shown in Table 1.
The PHQ-15 subscales and the total score were positively and significantly correlated with
COVID-19 anxiety, as well as with GAD-7 total score. These correlations are in line with
results from the first wave of the UK study [20]. Figure 1 shows the relationship between
COVID-19 anxiety and somatic symptoms.
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Table 1. Correlation table for all the variables included in Model 1.
Age Gender Income
C-19
Human
Losses
P.H.I. C-19Anxiety
PHQ-15
(Pain)
PHQ-15
(Gastro)
PHQ-15
(Cardio)
PHQ-15
(Fatigue)
PHQ-15
(Total)
Gender 0.19 ***
Income 0.00 0.12 ***
C-19
Human
Losses
−0.12 *** −0.09 ** −0.04
P.H.I. 0.21 *** 0.09 ** −0.07 * −0.05
GAD-7
(Total) −0.23 **** −0.13 **** −0.02 −0.28 *** 0.06
C-19
Anxiety −0.06 −0.14 **** −0.05 0.31 **** 0.01 0.23 ****
PHQ-15
(Pain) 0.07 * −0.09 ** −0.08 * 0.15 **** 0.19 **** 0.25 **** 0.10 **
PHQ-15
(Gastro) −0.23 **** −0.15 **** 0.00 0.25 **** 0.10 ** 0.35 **** 0.10 ** 0.46 ****
PHQ-15
(Cardio) −0.09 ** −0.13 **** 0.00 0.29 **** 0.19 **** 0.40 **** 0.12 *** 0.43 **** 0.59 ****
PHQ-15
(Fatigue) −0.07 * −0.13 **** −0.04 0.18 **** 0.18 **** 0.31 **** 0.13 *** 0.5*** 0.56 **** 0.51 ****
PHQ-15
(Total) −0.08 * −0.15 **** −0.04 0.24 **** 0.20 **** 0.36 **** 0.12 *** 0.75 **** 0.82 **** 0.71 **** 0.81 ****
Note. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001 (adjusted controlling the false discovery rate [32]). Abbreviations: C-19: COVID-19; P.H.I.: Previous Health Issues; GAD-7: Generalized Anxiety Disorder
7-item; PGQ-15: Patient Health Questionnaire-15.
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Figure 1. Relationship of COVID-19 anxiety on somatic symptoms (Model 2).
Table 2 shows the estimates from the regression models. In Model 1, considering
COVID-19 first quintile as no-anxiety, we can observe significant differences between the
baseline and the other quantiles both in PHQ-15 subscales and in its total score. In the
sample, the aggravation of the somatic symptoms between quintiles seems to be charac-
terized by a more linear increase than in the UK data, with a similar wider effect over the
5th quintile.
In Model 2, the control variables were taken into account. The effect of COVID-19
anxiety on somatic symptoms was weaker but similar to Model 1, especially referred to the
total scale score. The presence of pre-existing health problems and high scores on GAD-7
significantly worsen specific and general somatic symptoms, confirming UK’s findings.
Mourning for COVID-19 losses also has a detrimental effect on psychological health. No
effect of household income was found. In terms of regions, Campania showed higher
scores of somatic symptoms than the other regions. Campania scores were high in the
PHQ-15 pain subscale and in the gastrointestinal subscale, but also overall.
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Table 2. Regression coefficients from models predicting PHQ-15 scale and subscale scores.
Pain Gastro Cardio Fatigue Total Score
Model 1
COVID-19 anxiety
Quintile 1 - - - - -
Quintile 2 0.18 0.61 ** 0.33 * 0.23 * 1.36 **
Quintile 3 0.26 * 0.91 *** 0.55 *** 0.30 ** 2.03 ***
Quintile 4 0.26 * 0.89 *** 0.53 *** 0.47 *** 2.15 ***
Quintile 5 0.56 *** 1.20 *** 0.90 *** 0.72 *** 3.40 ***
R2 0.02 *** 0.04 *** 0.03 *** 0.04 *** 0.05 ***
Model 2
COVID-19 anxiety
Quintile 1 - - - - -
Quintile 2 0.13 0.42 * 0.22 0.14 0.92 *
Quintile 3 0.12 0.46 * 0.26 0.10 0.95 *
Quintile 4 0.08 0.37 0.19 0.23 0.87
Quintile 5 0.25 * 0.38 0.32 0.32 * 1.27 *
Control variables
Age 0.006 ** −0.01 *** 0.00 0.00 −0.02
Gender (Male) −0.18 * −0.30 * −0.24 * −0.20 * −0.93 **
Income (Max) −0.12 0.08 0.10 0.00 0.04
Health Problem (Yes) 0.52 *** 0.63 *** 0.60 *** 0.50 *** 2.27 ***
GAD-7 ≥ 10 0.75 *** 1.82 *** 1.48 *** 0.87 *** 4.93 ***
Region
Lazio −0.19 −0.17 −0.12 −0.14 −0.63
Lombardia −0.21 * −0.15 −0.09 −0.19 −0.64
Veneto −0.26 * −0.38 −0.19 −0.18 −1.03 *
Human Losses due to
COVID-19
Yes 0.30 * 0.71 *** 0.37 * 0.41 *** 1.80 ***
Not sure 0.43 * 0.34 0.09 0.34* 1.21
R2 0.14 *** 0.24 *** 0.22 *** 0.18 *** 0.27 ***
Note. * p < 0.05; ** p < 0.01; *** p < 0.001 (adjusted controlling the false discovery rate [32]).
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3.2. Anxiety, Depression, and Traumatic Stress
We focused on anxiety, depression, traumatic stress and COVID-19 related anxiety,
following Shevlin et al. (2020). In order to be consistent with the original study, traumatic
stress and COVID-19 related anxiety where treated independently, whereas a new variable
was computed to describe participants with anxiety, depression, or both. Sample size,
percentages and adjusted odds ratio are summarized in Tables 3–5.
Table 3. Multiple logistic regression results predicting anxiety or depression.
n Anxiety/Depression (n%) Adjusted OR (95% CI)
Age
1038 271 (26.10%) 0.962 (0.951–0.973) ***
Gender
Female 531 165 (31.07%) -
Male 507 106 (20.90%) 0.728 (0.406–1.048)
Living Location
Rural 49 11 (22.45%) -
Town 297 57 (19.19%) 0.960 (0.162–1.815)
Suburb 123 41 (33.33%) 1.648 (0.796–2.551)
City 569 162 (28.47%) 1.365 (0.592–2.200)
Lone Adult
No 899 238 (26.47%) -
Yes 139 33 (23.74%) 1.258 (0.759–1.744)
Children
No 680 131 (19.26%) -
Yes 358 140 (39.10%) 1.552 (1.203–1.902) **
Income
−15.000 €/yr 218 66 (30.27%) -
−28.000 €/yr 214 50 (23.36%) 0.709 (0.224–1.189)
−55.000 €/yr 212 50 (23.59%) 0.880 (0.380–1.377)
−75.000 €/yr 211 67 (31.75%) 1.039 (0.543–1.534)
+75.000 €/yr 183 38 (20.54%) 0.559 (0.009–1.100)
Pre-Existing Health Condition,
Self
No 869 222 (25.54%) -
Yes 169 49 (29.00%) 1.356 (0.911–1.813)
Pre-Existing Health Condition,
Relatives
No 811 192 (23.67%) -
Yes 227 79 (34.80%) 1.526 (1.145–1.906) **
Human Losses due to
COVID-19
No 888 217 (24.43%) -
Yes 109 38 (34.86%) 1.519 (1.017–2.012) *
Not Sure 41 16 (39.02%) 2.027 (1.267–2.771) **
Region
Campania 227 65 (28.63%) -
Lazio 234 61 (26.06%) 0.972 (0.504–1.440)
Lombardia 391 94 (24.04%) 0.728 (0.292–1.165)
Veneto 186 51 (27.42%) 0.912 (0.407–1.414)
Personal Risk at 1 Month
Low 269 33 (12.26%) -
Moderate—Low 252 46 (18.25%) 1.435 (0.924–1.955)
Moderate—High 261 75 (28.73%) 1.930 (1.453–2.423) ***
High 256 117 (45.70%) 2.565 (2.104–3.047) ***
Note. * p < 0.05; ** p < 0.01; *** p < 0.001 (adjusted controlling the false discovery rate [32]).
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Table 4. Multiple logistic regression results predicting COVID-19-related anxiety.
n C-19 Related Anxiety (n%) Adjusted OR (95% CI)
Age
1038 190 (26.10%) 1.001 (0.989–1.014)
Gender
Female 531 126 (23.73%) -
Male 507 64 (12.62%) 0.336 (−0.028–693) ***
Living Location
Rural 49 5 (10.20%) -
Town 297 62 (20.87%) 2.111 (1.147–3.265) *
Suburb 123 26 (21.14%) 1.648 (0.796–2.551)
City 569 97 (17.04%) 2.035 (0.994–3.238)
Lone Adult
No 899 170 (18.90%) -
Yes 139 20 (14.38%) 0.629 (0.051–1.168)
Children
No 680 112 (16.47%) -
Yes 358 78 (21.79%) 1.001 (1.595–1.402)
Income
−15.000 €/yr 218 51 (23.39%) -
−28.000 €/yr 214 42 (19.62%) 0.721 (0.214–1.223)
−55.000 €/yr 212 28 (13.20%) 0.219 (−0.353–0.775)
−75.000 €/yr 211 33 (15.64%) 0.389 (−0.171–0.937)
+75.000 €/yr 183 36 (19.67%) 0.949 (0.386–1.507)
Pre-Existing Health Condition,
Self
No 869 157 (18.06%) -
Yes 169 33 (19.52%) 1.015 (0.510–1.501)
Pre-Existing Health Condition,
Relatives
No 811 136 (16.77%) -
Yes 227 54 (23.7%) 1.325 (0.904–1.738)
Human Losses due to
COVID-19
No 888 159 (17.90%) -
Yes 109 23 (21.1%) 1.099 (0.541–1.628)
Not Sure 41 8 (19.51%) 1.283 (0.355–2.108)
Region
Campania 227 49 (21.58%) -
Lazio 234 42 (17.95%) 0.913 (0.402–1.421)
Lombardia 391 64 (16.37%) 0.719 (0.250–1.190)
Veneto 186 35 (18.81%) 0.935 (0.390–1.473)
Personal Risk at 1 Month
Low 269 17 (6.32%) -
Moderate–Low 252 33 (13.09%) 1.747 (1.134–2.392) *
Moderate–High 261 43 (16.47%) 1.956 (1.366–2.585) **
High 256 97 (37.89%) 3.196 (2.647–3.798) ***
Note. * p < 0.05; ** p < 0.01; *** p < 0.001 (adjusted controlling the false discovery rate [32]).
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Table 5. Multiple logistic regression results predicting traumatic stress.
n Traumatic Stress (n%) Adjusted OR (95% CI)
Age
1038 269 (25.91%) 0.968 (0.957–0.979) ***
Gender
Female 531 157 (29.56%) -
Male 507 112 (22.09%) 0.850 (0.532–1.168)
Living Location
Rural 49 13 (26.53%) -
Town 297 59 (19.86%) 0.670 (−0.092–1.475)
Suburb 123 33 (26.83%) 0.940 (0.109–1.803)
City 569 164 (28.82%) 1.049 (0.312–1.832)
Lone Adult
No 899 236 (26.25%) -
Yes 139 33 (23.74%) 1.243 (0.749–1.722)
Children
No 680 134 (19.70%) -
Yes 358 135 (37.70%) 1.520 (1.169–1.87) **
Income
−15.000 €/yr 218 60 (27.52%) -
−28.000 €/yr 214 52 (24.30%) 0.906 (0.425–1.386)
−55.000 €/yr 212 58 (27.36%) 1.259 (0.771–1.749)
−75.000 €/yr 211 63 (29.85%) 1.099 (0.600–1.597)
+75.000 €/yr 183 36 (19.67%) 0.657 (0.102–1.203)
Pre-Existing Health
Condition, Self
No 869 216 (24.85%) -
Yes 169 53 (31.36%) 1.587 (1.148–2.023) **
Pre-Existing Health Condition,
Relatives
No 811 197 (24.29%) -
Yes 227 72 (31.71%) 1.219 (0.836–1.597)
Human Losses due to
COVID-19
No 888 219 (24.66%) -
Yes 109 33 (30.27%) 1.207 (0.696–1.702)
Not Sure 41 17 (41.46%) 2.130 (1.386–2.886) **
Region
Campania 227 70 (30.83%) -
Lazio 234 57 (24.36%) 0.686 (0.223–1.146)
Lombardia 391 92 (23.53%) 0.519 (0.092–946) *
Veneto 186 50 (26.88%) 0.663 (0.168–1.154)
Personal Risk at 1 Month
Low 269 29 (10.78%) -
Moderate–Low 252 51 (20.24%) 1.782 (1.272–2.307) **
Moderate–High 261 69 (26.43%) 2.008 (1.519–2.518) ***
High 256 120 (46.87%) 2.815 (2.345–3.310) ***
Note. * p < 0.05; ** p < 0.01; *** p < 0.001 (adjusted controlling the false discovery rate [32]).
The rate of anxiety (GAD-7) in the overall sample was 21.59% (95% CI: 15.93%–20.72%),
with no differences between regions (χ2(3) = 4.07, p = 0.25) and with more women above the
anxiety cut-off (11.75%, men: 6.45%; χ2(1) = 15.94, p < 0.001). Depression (PHQ-9), with a
rate of 21.4% (95% CI: 18.95%–24.03%), showed no differences between regions (χ2(3) = 0.29,
p = 0.96) but was significantly higher among women (12.52%), compared to men (8.86%;
χ2(1) = 5.82, p = 0.016).
The rate of anxiety and/or depression was 26.11 (95% CI: 23.48%–28.91%). No signifi-
cant differences between regions were detected (χ2(3) = 1.78 p = 0.61), whereas the gender
difference was confirmed (women: 15.90%, men: 10.21%; χ2(1) = 13.37, p < 0.001).
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Using the ITQ scale, 25.92% of the sample was above the traumatic stress cut-off score
(95% CI: 23.34%–28.77%). No difference was found between regions (χ2(3) = 4.30, p = 0.23),
while the gender effect was again significant (women: 15.11%, men: 10.88%; χ2(1) = 7.16,
p = 0.007). Finally, COVID-19 related anxiety was 18.30% overall (95% CI: 16.02%–20.82%).
Regions showed a similar rate (χ2(3) = 2.66, p = 0.44) whereas a gender difference was found
(women: 12.14%, men: 6.17%; χ2(1) = 20–65, p < 0.001).
We considered anxiety and/or depression, traumatic stress, and COVID-19-related
Anxiety as dependent variables in three separate multiple logistic regressions (respectively,
Tables 3–5). Figure 2 shows the plot of the odds ratio for the model of traumatic stress.
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The age effect, observed by Shevlin and colleagues, was confirmed for anxiety/depression
(Adj OR = 0.96, CI = 0.95–0.97, p < 0.001), and traumatic stress (Adj OR = 0.97, CI = 0.96–0.98,
p < 0.001), showing more moderate cases in younger participants. A gender difference was
observed only in COVID-19 anxiety, with men less anxious than women about the new virus
(Adj OR = 0.33, CI = −0.03–0.69, p < 0.001). No differences were observed between regions.
The presence of minors in the house had a detrimental effect on anxiety/depression
(Adj OR = 1.55, CI = 1.20–1.90, p = 0.002) and traumatic stress (Adj OR = 1.52, CI = 1.17–1.87,
p = 0.004), as did the presence of pre-existing health conditions in others (anxiety/depression;
Adj OR = 1.53, CI = 1.14–1.91, p = 0.006) and themselves (traumatic stress; Adj OR = 1.59,
CI = 1.15–2.02; p = 0.008).
Interestingly, an increase in perceived risk to contract COVID-19 in the following four
weeks had an effect on depression/anxiety (LR χ2(3) = 54.24, p < 0.001), traumatic stress
(LR χ2(3) = 66.14, p < 0.001), and COVID-19 anxiety (LR χ2(3) = 84.74, p < 0.001), mostly in
the third and fourth quartile.
4. Discussion
This report provides an overview of the Italian C19CRP study to investigate the
psycho-social impact of the COVID-19 pandemic in the adult population. We aimed at
replicating the analyses of the first two UK studies [19,20]. First, we focused on replicating
the analyses by Shevlin et al. [20] about the somatic symptomatology and their relationship
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with anxiety. All the psychosomatic subscales showed positive correlations both with
COVID-19 anxiety and general anxiety (GAD-7) (Table 1). In our regression analysis,
higher COVID-19 anxiety was associated with more severe somatic symptomatology
(Model 1, Table 2). Compared to the UK, in Italy the somatic symptoms showed a more
linear relation between COVID-19 related anxiety and the somatic subscales and total score.
In Model 2, the individuals with higher COVID-19 anxiety displayed more severe
somatic symptoms. When considering covariates, gender, health problems, GAD-7 ≥ 10,
and human losses due to COVID-19 had a significant effect on somatic symptomatology.
No consistent effect of region or household income were observed, with the exception
of higher levels of somatic symptoms registered in the Campania region followed by the
Veneto region.
In a second part of the analysis, we replicated the approach by Shevlin et al. [19].
We conducted three logistic regressions with different outcomes: presence of moderate
anxiety/depression; presence of moderate traumatic stress symptoms; presence of high
COVID-19-related anxiety.
When the outcome variable was the presence of moderate symptoms of anxiety
and/or depression (Table 3), the factors associated with moderate symptoms of anxiety
and/or depression were younger age, having children, having pre-existing precarious
health conditions, mourning for COVID-19 losses, and perceiving a moderate to high risk
of contracting the COVID-19 virus within one month. Regarding the regions, no significant
results emerged.
If COVID-19 related anxiety is used as outcome (Table 4), being male had a protective
effect, whilst living in a town and perceiving a low-moderate to high risk of getting
COVID-19 within one month were associated with higher COVID-19 related anxiety.
When considering as dependent variable the presence of traumatic stress symptoms
above the clinical cut-off (Table 5), younger age, having children, having pre-existing precar-
ious health conditions, thinking about having lost someone due to COVID-19, and perceiv-
ing a low-moderate/high risk of contracting COVID-19 within one month were associated
with more severe traumatic stress symptoms. Regarding, regional differences, living in
Lombardia compared to Campania was associated with lower traumatic stress symptoms.
Across these models, an increase in the perceived risk to contract COVID-19 in the
following month was associated with depression/anxiety, traumatic stress, and COVID-
19 anxiety.
Summarizing, these results are in line with those of the UK study about anxiety,
depression, and traumatic stress [19]. The UK and Italian data identify factors associated
with worst psychological health: being a woman, younger age, having children, pre-
existing health issues of self or someone close, and the moderate to high perceived risk of
contracting COVID-19 within one month. Unlike Italy, in the UK lower household incomes
and having (had) the COVID-19 were associated with worst psychological health outcomes.
Despite the similar variables used in Italy and in UK, the comparison has to take into
account the differences in data collection in regard to the evolution of the epidemic. The
first wave in the UK was launched at the beginning of the lockdown while the Italian
first wave took place two months after the end of the first lockdown, thus focusing on
the adaptation to life with COVID-19. The literature shows that psychological distress
symptoms can last for years [13,33–35] and data from Italy confirms that the levels of
psychological distress are still considerable two months after the end of the lockdown.
Moreover, the literature about other infectious respiratory diseases (IRDs) (e.g., H1N1,
MERS, SARS) shows that it is important to monitor psychological health also after the
peak [34–36].
Regarding the differences among Italian regions, results suggest that in July 2020
the Campania and Lazio regions suffered a strong psychological impact of the COVID-19
pandemic. In particular in Campania somatic symptoms were more severe, compared to
Lombardia and Veneto (Model 2). COVID-19-related anxiety was higher in Campania than
in Lombardia (Table 3). This is counterintuitive given that Lombardia had been affected
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earlier and to a larger extent. There were no significant regional differences between
regions in term of anxiety/depression and traumatic stress. As for COVID-19 related
anxiety, this result appears counterintuitive, because on the basis of the differences in
infection rate and media coverage one may have expected Lombardia to have higher scores
than other regions.
There are a few factors that may have affected these results. As always, findings should
be contextualized with respect to the time and circumstances of data collection. Lombardia
and Veneto experienced COVID-19 issues for a longer period and had more contagions
than Lazio and Campania. Resilience may have increased over time [37]. Another possible
explanation concerns the role of media in transmission of threatening information, when the
data was gathered people in areas with higher infection rates (e.g., north vs. south; Italy vs.
UK) already received more threatening information, thus increasing their risk perception
but also their strength. A second factor is that in July 2020 attention was focused on the
central and southern regions because of seasonal tourism. This may be related to the
higher anxiety and somatic issues in the Campania region at this point in time. Finally,
as discussed in the introduction, one reason both Lombardia and Veneto were included
in our study is because they are geographically contiguous but had been differentially
affected by the pandemic. If differences reflect geography rather than extent of the health
emergency, these may also relate to differences in attitudes or approach to the survey in
different regions. Further investigations are necessary to clarify similarities and differences
between regions.
These findings from the Italian general population suggest that two months after the
end of lockdown the psychological distress was still present, and it was high for certain
categories of the population, such as women, the younger, and those with children. Our re-
sults are in line with the current literature about the impact of COVID-19 in Italy [10,38–40]
and worldwide [41] both in clinical and general population as well. To date, most of studies
focused on the negative consequences of COVID-19. An Italian study in general population
showed the COVID-19 massive effects with rates of psychological issues ranging around
41.8% for high distress, 32.1% for high anxiety, and 7.6% for PTSD symptomatology linked
to the virus [38]. Other Italian studies focused on the mental health of specific categories, as
parents [40] at higher risk of experiencing distress and young adults [39] who showed an in-
crease in internalizing and externalizing problems, anxiety, depression, somatic complaints,
and aggressive and rule-breaking behaviors.
The anxiety related to COVID-19 was associated with somatic symptomatology be-
yond general anxiety, thus suggesting that COVID-related issues (e.g., degree and type
of exposure to COVID-19) deserve clinical consideration. Moreover, results highlighted
the socio-demographic risk-factors associated with more severe psychological outcomes.
These indicators are useful to identify at-risk groups in the population which may need tar-
geted psychological interventions. Noteworthy, the perceived risk of contracting COVID-19
was considerable in the population. This may influence a number of outcomes ranging
from psychological issues, hygiene practices, precautionary behavior, attitudes toward
vaccine, trust in institutions, and beliefs in conspiracy theories. Future studies will focus
on the role of other aspects that are relevant for adaptation to living with the COVID-19 in
the Italian context.
The limitations of this study should be acknowledged. An online administration
methodology was used, this may bias the results because there may be differences between
the paper-pen administration and the online version. Self-report measures were used,
with potential well-known biases related to social desirability and misleading answers.
When the study was launched in UK, a broad number of measurement tools were used,
including already validated measures and tools developed ad hoc in order to reflect
the current psychological issues related to the COVID-19 emergency. Given that the
same measures were administered in Italy, socio-cultural differences suggest caution in
interpretation and in the direct comparison [20].
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An observational cross-sectional study design was used, whilst a longitudinal design
would be desirable to monitor the evolution of the COVID-19 impact. Future waves of
the survey would provide valuable information. Our analyses can only show association
and not causation. Finally, despite the well-balanced sample, a larger sample would better
capture and represent minorities.
The Italian C19PRC can contribute to ongoing research on health issues such as: the fac-
tors hindering resilience, the relationship between conspiracy theories and denial, the link
between trust in Institutions and compliance, the burden and clinical characteristics of psy-
chological issues, and the psychological heath of specific subgroups at higher risk for adverse
psychophysical outcomes. Moreover, comparing results in a broader international frame-
work allows cross-cultural comparisons. In addition to Italy and the UK, the international
consortium now includes the Republic of Ireland (from March 2020), Spain (from April 2020),
the United Arab Emirates (from April 2020), and Saudi Arabia (from May 2020).
Regarding the strengths of this research, respondents were recruited by using an
online research panel with stratified quota sampling to ensure that the sample would
meet the characteristics of sex, age, household income of the Italian population. Moreover,
the C19PRC Study was designed drawing from studies that investigated previous IRDs epi-
demics and their psychosocial impact (e.g., H1N1, MERS, SARS). To do so, several factors
were assessed to capture the complexity of the phenomenon from an ecological perspec-
tive, taking into account the demographic, social, political, economic, and psychological
influences. The findings of this project may be useful to understand and manage the
psycho-social implications of the COVID-19 pandemic.
5. Conclusions
The social and psychological impact of the COVID-19 pandemic is believed to be
severe and long-lasting. Behavioral changes and psychological impact need to be studied
over time and across countries. Therefore, the Italy COVID-19 study was modelled on the
UK COVID-19 study. This paper is only a first summary of the Italian data. Analyzing and
combining large datasets will allow a better understanding of the phenomena and in turn
the development of measure to safeguard the psychological health of individuals.
Supplementary Materials: The following are available online at https://www.mdpi.com/2077-0
383/10/1/52/s1, Table S1: Age; Table S2: Ethnicity (frequencies); Table S3: Level of education
(frequencies); Table S4: Occupation (frequencies); Table S5: Income (frequencies); Table S6: Financial
concern (1–10); Table S7: Religious belief (frequencies); Table S8: Marital status (frequencies); Table S9:
Individual and family health issues (frequencies); Table S10: COVID-19-related anxiety (0–100);
Table S11: Perceived personal risk in the next 30 days (0–100); Table S12: COVID-19 total participants
tested and confirmed cases (participants, relatives, friends); Table S13: Patient health questionnaire
(PHQ-15, range: 0–30); Table S14: PHQ-15, pain symptoms (range 0–6); Table S15: Gastrointestinal
symptoms (range 0–8); Table S16: PHQ-15, cardiopulmonary symptoms (range 0–8); Table S17:
PHQ-15, fatigue symptoms (range 0–4); Table S18: Patient Health Questionnaire-9 (PHQ-9, range
0–27); Table S19: International Trauma Questionnaire (ITQ, range 0–36); Table S20: Generalized Anxiety
Disorder 7-item Scale (GAD-7, range 0–21).
Author Contributions: Study conceptualization: M.B. and the C19PRC-UK; survey translation and
adaptation to Italian: all the authors; survey construction: G.B.; data collection: provided by Qualtrics
via University of Roma and University of Padua; data cleaning: G.B.; data analysis: G.B. and U.G.;
funding acquisition: G.V., F.L.; writing original draft: A.P. and G.B. (methods and results sections);
writing—review and editing: M.B., G.V.; supervision: M.B., G.V., A.S. All authors have read and
agreed to the published version of the manuscript.
Funding: This research was funded by the University “La Sapienza” of Roma and the Department of
General Psychology of the University of Padua.
Institutional Review Board Statement: The study was conducted according to the guidelines of the
Declaration of Helsinki, and approved by the Ethics Committee of the University of Padua (Area 17,
protocol code 3818, date of approval 03/11/2020).
J. Clin. Med. 2021, 10, 52 16 of 17
Informed Consent Statement: Informed consent was obtained from all subjects involved in the
study.
Data Availability Statement: Data is contained within the article or supplementary material. The data
presented in this study are available in [Supplementary material S1 and Tables S1–S20].
Acknowledgments: The present work was carried out within the scope of the research program “Di-
partimenti di Eccellenza” from MIUR to the Department of General Psychology, University of Padua.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Baud, D.; Qi, X.; Nielsen-Saines, K.; Musso, D.; Pomar, L.; Favre, G. Real estimates of mortality following COVID-19 infection.
Lancet Infect. Dis. 2020, 20, 773. [CrossRef]
2. Zaim, S.; Chong, J.H.; Sankaranarayanan, V.; Harky, A. COVID-19 and Multiorgan Response. Curr. Probl. Cardiol. 2020, 45, 100618.
[CrossRef] [PubMed]
3. Funk, S.; Salathé, M.; Jansen, V.A.A. Modelling the influence of human behaviour on the spread of infectious diseases: A review.
J. R. Soc. Interface 2010, 7, 1247–1256. [CrossRef] [PubMed]
4. Wind, T.R.; Rijkeboer, M.; Andersson, G.; Riper, H. The COVID-19 pandemic: The ‘black swan’ for mental health care and a
turning point for e-health. Internet Interv. 2020, 20, 100317. [CrossRef]
5. Forte, G.; Favieri, F.; Tambelli, R.; Casagrande, M. The Enemy Which Sealed the World: Effects of COVID-19 Diffusion on the
Psychological State of the Italian Population. J. Clin. Med. 2020, 9, 1802. [CrossRef]
6. Torales, J.; O’Higgins, M.; Castaldelli-Maia, J.M.; Ventriglio, A. The outbreak of COVID-19 coronavirus and its impact on global
mental health. Int. J. Soc. Psychiatry 2020, 66, 317–320. [CrossRef]
7. Cellini, N.; Canale, N.; Mioni, G.; Costa, S. Changes in sleep pattern, sense of time and digital media use during COVID-19
lockdown in Italy. J. Sleep Res. 2020, 29, e13074. [CrossRef]
8. Cerami, C.; Santi, G.C.; Galandra, C.; Dodich, A.; Cappa, S.F.; Vecchi, T.; Crespi, C. COVID-19 Outbreak in Italy: Are We Ready for the
Psychosocial and Economic Crisis? Baseline Findings from the Longitudinal PsyCovid Study. SSRN Electron. J. 2020. [CrossRef]
9. Rossi, A.; Panzeri, A.; Pietrabissa, G.; Manzoni, G.M.; Castelnuovo, G.; Mannarini, S. The Anxiety-Buffer Hypothesis in the Time
of COVID-19: When Self-Esteem Protects from the Impact of Lone-liness and Fear on Anxiety and Depression. Front. Psychol.
2020, 11, 2177. [CrossRef]
10. Rossi, R.; Socci, V.; Pacitti, F.; Di Lorenzo, G.; Di Marco, A.; Siracusano, A.; Rossi, A. Mental Health Outcomes Among Frontline
and Second-Line Health Care Workers During the Coronavirus Disease 2019 (COVID-19) Pandemic in Italy. JAMA Netw. Open
2020, 3, e2010185. [CrossRef]
11. Yang, Y.; Li, W.; Zhang, Q.; Zhang, L.; Cheung, T.; Xiang, Y.-T. Mental health services for older adults in China during the
COVID-19 outbreak. Lancet Psychiatry 2020, 7, e19. [CrossRef]
12. Yao, H.; Chen, J.-H.; Xu, Y.-F. Patients with mental health disorders in the COVID-19 epidemic. Lancet Psychiatry 2020, 7, e21. [CrossRef]
13. Kang, L.; Wang, G.; Liu, Z. Targeted long-term mental health services in Wuhan dealing with COVID-19. Eur. Arch. Psychiatry
Clin. Neurosci. 2020, 1–3. [CrossRef]
14. Gardner, P.J.; Moallef, P. Psychological impact on SARS survivors: Critical review of the English language literature. Can. Psychol.
Can. 2015, 56, 123–135. [CrossRef]
15. Gatto, M.; Bertuzzo, E.; Mari, L.; Miccoli, S.; Carraro, L.; Casagrandi, R.; Rinaldo, A. Spread and dynamics of the COVID-19 epidemic in
Italy: Effects of emergency containment measures. Proc. Natl. Acad. Sci. USA 2020, 117, 10484–10491. [CrossRef] [PubMed]
16. McBride, O.; Murphy, J.; Shevlin, M.; Gibson-Miller, J.; Hartman, T.K.; Hyland, P.; Levita, L.; Mason, L.; Martinez, A.P.; McKay, R.;
et al. Monitoring the psychological, social, and economic impact of the COVID-19 pandemic in the population: Context, design
and conduct of the longitudinal COVID-19 psychological research consortium (C19PRC) study. Int. J. Methods Psychiatr. Res. 2020,
e1861. [CrossRef] [PubMed]
17. Ministero della Salute, Istituto Superiore della Sanità. Report Monitoraggio Settimanale Covid-19: “Lieve Aumento
dei Casi. Rispettare Misure di Precauzione”. Available online: http://www.salute.gov.it/portale/nuovocoronavirus/
dettaglioNotizieNuovoCoronavirus.jsp?menu=notizie&p=dalministero&id=4971 (accessed on 15 November 2020).
18. Berardi, C.; Antonini, M.; Genie, M.G.; Cotugno, G.; Lanteri, A.; Melia, A.; Paolucci, F. The COVID-19 pandemic in Italy: Policy
and technology impact on health and non-health outcomes. Health Policy Technol. 2020, 9, 454–487. [CrossRef]
19. Shevlin, M.; McBride, O.; Murphy, J.; Miller, J.G.; Hartman, T.K.; Levita, L.; Mason, L.; Martinez, A.P.; McKay, R.; Stocks, T.V.A.;
et al. Anxiety, depression, traumatic stress and COVID-19-related anxiety in the UK general population during the COVID-19
pandemic. BJPsych Open 2020, 6. [CrossRef]
20. Shevlin, M.; Nolan, E.; Owczarek, M.; McBride, O.; Murphy, J.; Gibson Miller, J.; Hartman, T.K.; Levita, L.; Mason, L.; Martinez, A.P.;
et al. COVID-19-related anxiety predicts somatic symptoms in the UK population. Br. J. Health Psychol. 2020, 25, 875–882. [CrossRef]
21. R Core Team. R: A Language and Environment for Statistical Computing; R Foundation for Statistical Computing: Vienna, Austria, 2018.
22. Kroenke, K.; Spitzer, R.L.; Williams, J.B.W. The PHQ-15: Validity of a New Measure for Evaluating the Severity of Somatic
Symptoms. Psychosom. Med. 2002, 64, 258–266. [CrossRef]
J. Clin. Med. 2021, 10, 52 17 of 17
23. Cano-García, F.J.; Muñoz-Navarro, R.; Abad, A.S.; Moretti, L.S.; Medrano, L.A.; Ruiz-Rodríguez, P.; González-Blanch, C.; Moriana,
J.A.; Cano-Vindel, A. Latent structure and factor invariance of somatic symptoms in the patient health questionnaire (PHQ-15). J.
Affect. Disord. 2020, 261, 21–29. [CrossRef] [PubMed]
24. Kroenke, K.; Spitzer, R.L.; Williams, J.B.W. The Patient Health Questionnaire (PHQ-9)—Overview. J. Gen. Intern. Med. 2001, 16,
606–616. [CrossRef] [PubMed]
25. Manea, L.; Gilbody, S.; McMillan, D. Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire
(PHQ-9): A meta-analysis. Can. Med Assoc. J. 2011, 184, E191–E196. [CrossRef] [PubMed]
26. Spitzer, R.L.; Kroenke, K.; Williams, J.B.W.; Löwe, B. A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7.
Arch. Intern. Med. 2006, 166, 1092. [CrossRef]
27. Hinz, A.; Klein, A.M.; Brähler, E.; Glaesmer, H.; Luck, T.; Riedel-Heller, S.G.; Wirkner, K.; Hilbert, A. Psychometric evaluation of
the Generalized Anxiety Disorder Screener GAD-7, based on a large German general population sample. J. Affect. Disord. 2017,
210, 338–344. [CrossRef]
28. Cloitre, M.; Shevlin, M.; Brewin, C.R.; Bisson, J.I.; Roberts, N.P.; Maercker, A.; Karatzias, T.; Hyland, P. The International
Trauma Questionnaire: Development of a self-report measure of ICD-11 PTSD and com-plex PTSD. Acta Psychiatr. Scand. 2018,
138, 536–546. [CrossRef]
29. World Health Organization. International Classification of Diseases for Mortality and Morbidity Statistics (11th Revision, 2018).
Available online: https://icd.who.int/browse11/l-m/en (accessed on 15 November 2020).
30. Ben-Ezra, M.; Karatzias, T.; Hyland, P.; Brewin, C.R.; Cloitre, M.; Bisson, J.I.; Roberts, N.P.; Lueger-Schuster, B.; Shevlin, M.
Posttraumatic stress disorder (PTSD) and complex PTSD (CPTSD) as per ICD-11 proposals: A population study in Israel. Depress.
Anxiety 2018, 35, 264–274. [CrossRef]
31. Cloitre, M.; Hyland, P.; Bisson, J.I.; Brewin, C.R.; Roberts, N.P.; Karatzias, T.; Shevlin, M. ICD-11 Posttraumatic Stress Disorder and
Complex Posttraumatic Stress Disorder in the United States: A Population-Based Study. J. Trauma. Stress 2019, 32, 833–842. [CrossRef]
32. Benjamini, Y.; Hochberg, Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. R. Stat.
Soc. Ser. B Stat. Methodol. 1995, 57, 289–300. [CrossRef]
33. Bonanno, G.A.; Ho, S.M.Y.; Chan, J.C.K.; Kwong, R.S.Y.; Cheung, C.K.Y.; Wong, C.P.Y.; Wong, V.C.W. Psychological resilience and
dysfunction among hospitalized survivors of the SARS epidemic in Hong Kong: A latent class approach. Health Psychol. 2008,
27, 659–667. [CrossRef]
34. Chen, J.; Wu, J.; Hao, S.; Yang, M.; Lu, X.; Chen, X.; Li, L. Long term outcomes in survivors of epidemic Influenza A (H7N9) virus
infection. Sci. Rep. 2017, 7, 1–8. [CrossRef] [PubMed]
35. Lee, A.M.; Wong, J.G.W.S.; McAlonan, G.M.; Cheung, V.; Cheung, C.; Sham, P.C.; Chu, C.-M.; Wong, P.-C.; Tsang, K.W.T.; Chua,
S.E. Stress and Psychological Distress among SARS Survivors 1 Year after the Outbreak. Can. J. Psychiatry 2007, 52, 233–240.
[CrossRef] [PubMed]
36. Esterwood, E.; Saeed, S.A. Past Epidemics, Natural Disasters, COVID19, and Mental Health: Learning from History as we Deal
with the Present and Prepare for the Future. Psychiatr. Q. 2020, 91, 1121–1133. [CrossRef] [PubMed]
37. Seery, M.D.; Holman, E.A.; Silver, R.C. Whatever does not kill us: Cumulative lifetime adversity, vulnerability, and resilience.
J. Pers. Soc. Psychol. 2010, 99, 1025–1041. [CrossRef]
38. Casagrande, M.; Favieri, F.; Tambelli, R.; Forte, G. The enemy who sealed the world: Effects quarantine due to the COVID-19 on
sleep quality, anxiety, and psychological distress in the Italian population. Sleep Med. 2020, 75, 12–20. [CrossRef]
39. Parola, A.; Rossi, A.; Tessitore, F.; Troisi, G.; Mannarini, S. Mental Health through the COVID-19 Quarantine: A Growth Curve
Analysis on Italian Young Adults. Front. Psychol. 2020, 11, 567484. [CrossRef]
40. Spinelli, M.; Lionetti, F.; Pastore, M.; Fasolo, M. Parents and Children Facing the COVID-19 Outbreak in Italy. SSRN Electron. J.
2020. [CrossRef]
41. Xiong, J.; Lipsitz, O.; Nasri, F.; Lui, L.M.W.; Gill, H.; Phan, L.; Chen-Li, D.; Iacobucci, M.; Ho, R.; Majeed, A.; et al. Impact of COVID-19
pandemic on mental health in the general population: A systematic review. J. Affect. Disord. 2020, 277, 55–64. [CrossRef]
